CORC

在结果中检索

CORC

浏览/检索结果: 共66条，第1-10条 帮助

限定条件        
已选(0)清除 条数/页：   排序方式：
A China-manufactured bevacizumab biosimilar, HLX04, matches bevacizumab sourced from China, USA and the European Union 会议论文
作者:  Ding, Y.;  Yu, T.;  Sun, J.;  Wu, M.;  Chen, Q.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
First china-manufactured proposed rituximab biosimilar met primary efficacy and safety endpoints in CD20-positive diffuse large B-cell lymphoma (generics) 会议论文
作者:  Zhang, H.;  Shi, Y.;  Zhang, Q.;  Han, X.;  Song, Y.
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Global clinical trials validating bioequivalence with China-manufactured trastuzumab biosimilar, HLX02, and trastuzumab 会议论文
作者:  Zhang, Q.;  Xu, B.;  Zhang, Q.;  Sun, T.;  Li, W.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
Global clinical trials validating bioequivalence with China-manufactured trastuzumab biosimilar, HLX02, and trastuzumab 会议论文
作者:  Xu, B.;  Luk, A.;  Liu, S.;  Jiang, W.;  Liu, E.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
First-line cetuximab plus cisplatin and fluorouracil vs cisplatin and fluorouracil in Chinese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: The randomized, phase III CHANGE-2 trial 会议论文
作者:  Guo, Y.;  Luo, Y.;  Zhang, Q.;  Huang, X.;  Li, Z.
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
A novel method of measuring exosomal HER2 to assist in selecting advanced gastric cancer patients benefiting from anti-HER2 therapy 会议论文
作者:  Cai, S.;  Li, Q.;  Xu, X.;  Yu, Y.;  Li, W.
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05
OLAPARIB MAINTENANCE MONOTHERAPY IMPROVES PROGRESSION-FREE SURVIVAL (PFS) IN PATIENTS WITH PLATINUM-SENSITIVE RELAPSED OVARIAN CANCER (PSROC): SOLO2 STUDY - CHINA COHORT 会议论文
作者:  Liu, J.;  Yin, R.;  Wu, L.;  Zhu, J.;  Lou, G.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Features of Idiopathic Membranous Nephropathy in Elderly Patients and Its Correlation with the Expression of PLA2R 会议论文
作者:  Liu, X. B.;  Zhang, Q. H.;  Zhang, Y.;  Chen, Y.;  Liu, S. J.
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05
First china-manufactured proposed rituximab biosimilar met primary efficacy and safety endpoints in CD20-positive diffuse large B-cell lymphoma (generics) 会议论文
作者:  Shi, Y.;  Zhang, Q.;  Han, X.;  Song, Y.;  Qin, Y.
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
Concurrent ALK/EGFR Alterations in Chinese Lung Cancers: Frequency, Clinical Features, and Differential Response to Therapy 会议论文
作者:  Ma, Y.;  Wu, D.;  Liu, J.;  Mu, Z.;  Liu, L.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace